Immuno-Biological Laboratories Co.,Ltd. (4570.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 1,146.00

From 52W high−70.03%

Volume189700.00

Market capJPY 10.66B

P/E (TTM)29.0x

P/S (TTM)9.9x

Div yield0.52%

Key dataSep 18, 2026

Open

JPY 1,146.00

From 52W high

−70.03%

Volume

189700.00

Market cap

JPY 10.66B

ValuationView details →

P/E (Fwd)

46.9x

EV/EBITDA

27.0x

P/E (TTM)

29.0x

RSI (14)

64.2

MomentumView details →

1D Return

−0.69%

YTD Return

−37.41%

ValuationView details →

P/E (Fwd)

46.9x

P/E (TTM)

29.0x

EV/EBITDA

27.0x

EV/Sales

9.2x

P/S (TTM)

9.9x

P/B (TTM)

5.6x

ProfitabilityView details →

Gross Margin

70.42%

Net Margin

32.77%

EBITDA Margin

29.83%

ROE (TTM)

17.85%

ROA (TTM)

15.27%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+3.61%

EPS YoY

+32.13%

FCF YoY

—

Revenue CAGR 3Y

+8.14%

EPS CAGR 3Y

+32.74%

EBITDA YoY

—

MomentumView details →

1D Return

−0.69%

YTD Return

−37.41%

1Y Return

+151.80%

RSI (14)

64.2

vs 50D SMA

+14.58%

vs 200D SMA

−12.16%

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

5.68x

Quick Ratio

5.43x

Div Yield

0.52%

Div Rate

JPY 6.00

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.00B

Net Income (TTM)

329.00M

Op. CF (TTM)

—

Next earningsOct 30, 2026 →

Latest newsMore news →

Immuno-Biological Laboratories announced it will close its Mikasa Laboratory in Mikasa, Hokkaido at the end of May 2027 and consolidate its manufacturing functions into the Maebashi Laboratory in Maebashi, Gunma.5d ago

Immuno-Biological Laboratories completed the animal testing part of the GLP-compliant repeated-dose toxicity study for anti-HIV antibodies related to jointly held patents.24d ago

Similar companies

StemRIM Inc.4599.T WAKAMOTO PHARMACEUTICAL CO.,LTD.4512.T KAINOS Laboratories,Inc.4556.T K Pharma,Inc.4896.T MORISHITA JINTAN CO.,LTD.4524.T AnGes,Inc.4563.T Find similar companies →

Latest newsMore news →

Immuno-Biological Laboratories announced it will close its Mikasa Laboratory in Mikasa, Hokkaido at the end of May 2027 and consolidate its manufacturing functions into the Maebashi Laboratory in Maebashi, Gunma.5d ago Immuno-Biological Laboratories completed the animal testing part of the GLP-compliant repeated-dose toxicity study for anti-HIV antibodies related to jointly held patents.24d ago